Kymera Therapeutics Inc (KYMR)
34.94
-0.66
(-1.85%)
USD |
NASDAQ |
May 17, 16:00
34.94
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics 1 Year Total Returns (Daily): 17.52% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 17.52% |
May 16, 2024 | 22.67% |
May 15, 2024 | 20.20% |
May 14, 2024 | 23.77% |
May 13, 2024 | 35.31% |
May 10, 2024 | 33.26% |
May 09, 2024 | 39.24% |
May 08, 2024 | 38.79% |
May 07, 2024 | 32.51% |
May 06, 2024 | 32.02% |
May 03, 2024 | 21.04% |
May 02, 2024 | 19.76% |
May 01, 2024 | 15.12% |
April 30, 2024 | 6.59% |
April 29, 2024 | 9.89% |
April 26, 2024 | 3.34% |
April 25, 2024 | 1.21% |
April 24, 2024 | 6.41% |
April 23, 2024 | 2.50% |
April 22, 2024 | -1.41% |
April 19, 2024 | -1.74% |
April 18, 2024 | 0.57% |
April 17, 2024 | -3.16% |
April 16, 2024 | 3.26% |
April 15, 2024 | 4.66% |
Date | Value |
---|---|
April 12, 2024 | 12.42% |
April 11, 2024 | 18.65% |
April 10, 2024 | 13.42% |
April 09, 2024 | 20.97% |
April 08, 2024 | 16.98% |
April 05, 2024 | 21.94% |
April 04, 2024 | 21.53% |
April 03, 2024 | 25.06% |
April 02, 2024 | 27.03% |
April 01, 2024 | 33.04% |
March 28, 2024 | 42.81% |
March 27, 2024 | 39.43% |
March 26, 2024 | 34.64% |
March 25, 2024 | 34.67% |
March 22, 2024 | 44.55% |
March 21, 2024 | 35.93% |
March 20, 2024 | 30.98% |
March 19, 2024 | 27.48% |
March 18, 2024 | 26.68% |
March 15, 2024 | 30.36% |
March 14, 2024 | 25.03% |
March 13, 2024 | 35.53% |
March 12, 2024 | 41.43% |
March 11, 2024 | 42.92% |
March 08, 2024 | 31.23% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.97%
Minimum
Jun 13 2022
145.9%
Maximum
Sep 09 2021
-11.00%
Average
-19.77%
Median
Aug 04 2023
1 Year Total Returns (Daily) Benchmarks
Immunic Inc | -31.22% |
Insmed Inc | 33.46% |
SELLAS Life Sciences Group Inc | -13.61% |
Iovance Biotherapeutics Inc | 36.53% |
Intellia Therapeutics Inc | -40.14% |